Canada markets open in 35 minutes

BioVaxys Technology Corp. (BIOV.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.0850+0.0050 (+6.25%)
At close: 09:48AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-10-31
2021-10-31
2020-10-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
257.604
962.708
726.057
238.774
Selling General and Administrative
2,181
2,835
5,253
763.278
Total Operating Expenses
3,184
4,082
6,442
1,098
Operating Income or Loss
-3,184
-4,082
-6,442
-1,098
Total Other Income/Expenses Net
-9,397
-7,661
-23.562
-4.375
Income Before Tax
-12,567
-11,727
-6,458
-1,103
Income from Continuing Operations
-12,567
-11,727
-6,458
-1,103
Net Income
-12,567
-11,727
-6,458
-1,174
Net Income available to common shareholders
-12,567
-11,727
-6,458
-1,174
Basic EPS
-0.12
-0.12
-0.08
-0.04
Diluted EPS
-0.12
-0.12
-0.08
-0.04
Basic Average Shares
124,307
98,180
82,930
28,211
Diluted Average Shares
124,307
98,180
82,930
28,211